Home › Funds › Monaco Asset Management SAM › RCKT
Monaco Asset Management SAM position in RCKT
ROCKET PHARMACEUTICALS INC · Health Care
Monaco Asset Management SAM reported holding 2,920,490 shares of RCKT (ROCKET PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 1.10% of its reported portfolio and ranking #16 among its reported holdings. Monaco Asset Management SAM has disclosed RCKT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Monaco Asset Management SAM's RCKT position evolved
Monaco Asset Management SAM first disclosed a stake in RCKT in Q2 2025 at 452,767 shares (US$1.1M). The position peaked in Q4 2025 at 2,987,296 shares, worth US$10.5M. Across 6 filings, Monaco Asset Management SAM increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,920,490 shares valued at US$7.7M — an increase of 440,022 shares quarter over quarter.. Notable position changes include a 539% increase in Q3 2025 (shares rose 8% over the following quarter), a 31% trim in Q1 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 452.77K | $1.11M | New |
| Q3 2025 | 2.89M | $9.43M | Add |
| Q4 2025 | 2.99M | $10.49M | Add |
| Q1 2026 | 2.06M | $7.37M | Reduce |
| Q2 2026 | 2.48M | $8.48M | Add |
| Q3 2026 | 2.92M | $7.68M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RCKT and 13F data
RCKT (ROCKET PHARMACEUTICALS INC) is a Health Care company. 14 other funds we track also report a position in RCKT — the largest reported positions include RTW INVESTMENTS, LP (US$60.5M), Newtyn Management, LLC (US$13.7M), Maverick Capital (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RCKT
- RTW INVESTMENTS, LP 17.69M sh · $60.49M · Q2 2026
- Newtyn Management, LLC 4.00M sh · $13.68M · Q2 2026
- Maverick Capital 3.92M sh · $13.42M · Q2 2026
- MAVERICK CAPITAL LTD 3.92M sh · $13.42M · Q2 2026
More on Monaco Asset Management SAM
FAQ
How long has Monaco Asset Management SAM held RCKT?
Monaco Asset Management SAM has disclosed RCKT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Monaco Asset Management SAM's current position in RCKT?
As of Q3 2026, Monaco Asset Management SAM holds 2.92M shares of RCKT (ROCKET PHARMACEUTICALS INC), valued at $7.68M, representing 1.10% of its reported portfolio and ranking #16.
Has Monaco Asset Management SAM been buying or selling RCKT?
In the latest 13F filing (Q3 2026), Monaco Asset Management SAM increased its position in RCKT. The position peaked in Q4 2025 at 2.99M shares.
Which other funds hold RCKT?
Other major institutional holders of RCKT include RTW INVESTMENTS, LP, Newtyn Management, LLC, Maverick Capital, among 14 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.